Riskpilot← Back to searchSign inGet full accessSENTRUM REISEMEDISIN AS
ASActiveOrg 986399178Strandgaten 6, 5013 BergenOther human health activities n.e.c. · NACE 8699Est. 200413 employeeswww.reisemedisin.no
Revenue 2024
NOK 10,9M
+59% vs 2023
EBITDA margin
5.0%
-18% vs 2023
Equity ratio
65.5%
Financial strength
Net profit 2024
NOK 469K
-33% vs 2023
| Revenue | NOK 10,9M | +59% |
| EBITDA | NOK 545K | -18% |
| Net profit | NOK 469K | -33% |
| Total assets | NOK 4,1M | +27% |
| Equity | NOK 2,7M | +21% |
| Employees | 13 | — |
Legal name
SENTRUM REISEMEDISIN AS
Org number
986399178
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
24. februar 2004
Share capital
NOK 102 000
Employees
13 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Reisemedisinsk rådgivning, vaksinasjon og salg av reiserelaterte produkter.
Address
Strandgaten 6, 5013 Bergen
Phone
+4755962770
Email
sentrum@reisemedisin.no
Website
www.reisemedisin.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2009 | 2010 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4 068 | 4 600 | 0 | 0 | 4 455 | 4 777 | 5 811 | 5 565 | 7 049 | 8 025 | 3 016 | 3 201 | 5 501 | 6 879 | 10 941 |
| Staff expenses | −1 041 | −1 685 | −0 | −0 | −1 739 | −1 660 | −1 764 | −1 942 | −2 367 | −2 741 | −1 325 | −2 104 | −2 889 | −1 720 | −2 848 |
| EBITDA | 468 | 21 | 0 | 0 | −114 | 66 | 377 | −169 | 43 | −105 | −685 | −47 | −235 | 668 | 545 |
| Depreciation & amort. | −17 | −12 | −0 | −0 | −9 | −6 | −4 | −10 | −13 | −44 | −31 | −50 | −4 | −4 | −6 |
| EBIT | 451 | 9 | 0 | 0 | −122 | 60 | 373 | −178 | 30 | −149 | −716 | −97 | −239 | 665 | 539 |
| Net financials | −50 | 16 | 0 | 0 | 113 | 10 | 5 | 170 | 7 | 82 | 5 | 266 | 251 | 33 | 84 |
| Profit before tax | 401 | 25 | 0 | 0 | −9 | 70 | 378 | −8 | 37 | −67 | −711 | 170 | 12 | 697 | 623 |
| Tax | 139 | 6 | −0 | −0 | −0 | 20 | 95 | −1 | 9 | −10 | −0 | −2 | −0 | −0 | 154 |
| Net profit | 262 | 19 | 0 | 0 | −9 | 50 | 283 | −7 | 28 | −58 | −711 | 172 | 12 | 697 | 469 |
| Item | 2009 | 2010 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 773 | 1 856 | — | — | 2 353 | 2 403 | 2 795 | 3 144 | 3 218 | 3 523 | 1 741 | 2 199 | 3 070 | 3 206 | 4 063 |
| Equity | 1 183 | 1 186 | — | — | 1 725 | 1 775 | 2 058 | 2 051 | 2 079 | 2 021 | 1 310 | 1 481 | 1 493 | 2 191 | 2 659 |
| Long-term debt | 0 | 0 | 0 | 0 | 1 | 1 | 4 | 3 | 10 | 0 | 0 | 0 | 0 | 0 | 2 |
| Short-term debt | 591 | 670 | 0 | 0 | 628 | 628 | 733 | 1 090 | 1 129 | 1 502 | 431 | 718 | 1 576 | 1 015 | 1 402 |
| Total debt | 591 | 670 | 0 | 0 | 629 | 628 | 737 | 1 093 | 1 139 | 1 502 | 431 | 718 | 1 576 | 1 015 | 1 404 |
EBITDA margin
5.0%
This company
15.8%
Market median
-68% vs market
20092024
Equity ratio
65.5%
This company
38.2%
Market median
+71% vs market
20092024
Return on equity
17.6%
This company
18.4%
Market median
+4% vs market
20092024
Net profit margin
4.3%
This company
8.1%
Market median
-47% vs market
20092024
Asset turnover
2.69×
This company
1.12×
Market median
+140% vs market
20092024
Debt / equity
0.53×
This company
0.62×
Market median
+15% vs market
20092024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
EB Chief Executive Officer | Chief Executive Officer | 2004 | — | — |
PL Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2024 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SENTRUM REISEMEDISIN AS 
SENTRUM REISEMEDISIN GRIMSTAD ASBoard members of SENTRUM REISEMEDISIN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Elin Brautaset | Chief Executive Officer | 0 companies |
| Petter Lave Thornam | Chief Executive Officer | 0 companies |
| Camilla Brautaset | Board of Directors | 0 companies |
| Bjørn Standal | Board of Directors | 0 companies |
| Hildegun Sæverud | Board of Directors | 0 companies |